New research article
A new research article resulting from a collaboration between the Institut de Cancérologie de Lorraine, bladder cancer company Photocure and ETAP-Lab was recently published in the journal Biomedicines: “Antitumor Effect and Induced Immune Response Following Exposure of Hexaminolevulinate and Blue Light in Combination with Checkpoint Inhibitor in an Orthotopic Model of Rat Bladder Cancer”
This article reports on the effectiveness of a new therapy for the treatment of bladder cancer. By means of longitudinal follow-up over a period of up to 30 days, and supported by histology and immunohistochemistry results, the findings highlight the effectiveness of the combination of photodynamic therapy and a checkpoint inhibitor.
>> For more details: Photocure Press Release
We’d like to take this opportunity to congratulate all the authors for their work.Contact Us